Department of Speech & Language Therapy, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Department of Health Sciences, Speech and Language Therapy, European University, Nicosia, Cyprus.
Neurogastroenterol Motil. 2024 Jun;36(6):e14790. doi: 10.1111/nmo.14790. Epub 2024 Mar 28.
The Gugging Swallowing Screen (GUSS) is a bedside dysphagia screening tool that has been designed to determine the risk of aspiration in acute stroke patients. There is no evidence in the literature for the GUSS for the pediatric population. The present study aimed to determine the diagnostic accuracy of GUSS as a screening tool in the Greek language for children with dysphagia.
Eighty-Greek-Cypriot children aged 3-12 years who had dysphagia participated in this retrospective study. The translated into Greek GUSS was administered twice (pre- and post-therapy) to each patient throughout 24 sessions of dysphagia therapy.
The GUSS showed a high internal consistency (Cronbach's α = 0.826), good test-retest reliability (r = 0.767), convergent validity compared to the Greek Pediatric Eating Assessment tool-10 (PEDI-EAT-10) total score (r = -0.365), and inter-rater reliability (κ = 0.863). A total cutoff points equal to 13.00 was also calculated. Aspiration was identified by the GUSS with low sensitivity and high specificity (PPV 100%, NPV 57%, LR+ NA, LR- 0.79); dysphagia/penetration was identified with high sensitivity and low specificity (PPV 33%, NPV 100%, LR+ 0.102, LR- NA).
CONCLUSIONS & INFERENCES: The pediatric version of GUSS has been found to be a valuable tool in identifying the risk of aspiration as that of adults. It proved to be used as a good screening guide for selecting and confirming the existence of dysphagia from instrumental assessments. This is the first study of the pediatric version of GUSS, and future studies on this topic are needed.
Gugging 吞咽筛查（GUSS）是一种床边吞咽障碍筛查工具，旨在确定急性脑卒中患者发生吸入的风险。目前文献中尚无 GUSS 用于儿科人群的证据。本研究旨在确定希腊语 GUSS 作为一种筛查工具在希腊语儿童吞咽障碍中的诊断准确性。
本回顾性研究纳入了 80 名 3-12 岁的希腊塞浦路斯吞咽障碍儿童。每位患者在 24 次吞咽障碍治疗期间共进行了两次（治疗前和治疗后）翻译成希腊语的 GUSS 测试。
GUSS 显示出较高的内部一致性（Cronbach's α=0.826），良好的重测信度（r=0.767），与希腊儿科饮食评估工具-10（PEDI-EAT-10）总分的相关性（r=-0.365），以及观察者间信度（κ=0.863）。还计算了总截断值等于 13.00。GUSS 识别出的吸入具有较低的敏感性和较高的特异性（PPV 100%，NPV 57%，LR+无，LR-0.79）；吞咽/渗透具有较高的敏感性和较低的特异性（PPV 33%，NPV 100%，LR+0.102，LR-无）。
儿童版 GUSS 被发现是一种识别成人吸入风险的有价值的工具。它被证明可以作为一种很好的筛选工具，用于从仪器评估中选择和确认吞咽障碍的存在。这是儿童版 GUSS 的第一项研究，需要进一步研究。
